Nyrada Inc: NYR Completes Safety Studies Ahead of Phase I Clinical Trial
Nyrada Inc: Brain Injury Program GLP Studies Further Update 6
Nyrada Inc: Investor Presentation
Nyrada Inc: Drug Candidate Demonstrates Significant Cardioprotection
Nyrada Inc: Trading Halt
Nyrada Inc: Pause in Trading
Nyrada Inc: 2024 Annual General Meeting Access Letter, Notice and Proxy
Nyrada Inc: Brain Injury Program GLP Studies Further Update 5
Nyrada Inc: Investor Presentation
Nyrada Inc: Brain Injury Program GLP Studies Further Update 4
Nyrada Inc: Full Year Results FY2024
Nyrada Inc: Annual Report for year ended 30 June 2024
Nyrada Inc: Appendix 4G and Corporate Governance Statement
Nyrada Inc: Preliminary final report
Nyrada Inc: Brain Injury Program GLP Studies Further Update No 3
Nyrada Inc: Investor Presentation
Nyrada Inc: Brain Injury Program GLP Studies Further Update
Nyrada Inc: GLP Studies Update
Nyrada Inc: Nyrada Quarterly Activities Report & Appendix 4C
Nyrada Inc: Notification of cessation of securities - NYR
No Data
No Data